March 31st, 2017   |   Posted in Relapse, Treatment   |   By: Antonia Palmer   |   0 comments

DFMO is an interesting drug, and one that is currently being considered for a future clinical trial in Canada for children with neuroblastoma. There is a great deal to understand about this drug – both in how it works and the process for opening up a clinical trial in Canada.


G-CSF and Neuroblastoma

December 10th, 2015   |   Posted in Treatment   |   By: Antonia Palmer   |   0 comments

In May 2015, neuroblastoma families became increasingly concerned about the use of G-CSF in treatment due to emerging research findings. This article reviews that research in hopes of providing some clarity.


MIBG Therapy for High-Risk Neuroblastoma

June 1st, 2015   |   Posted in Treatment   |   By: Antonia Palmer   |   1 comment

The science and understanding of MIBG therapy for high-risk neuroblastoma continues to evolve and change. This article reviews past research, current practices and future directions of the treatment.


Counting the Cost

September 9th, 2014   |   Posted in Awareness   |   By: Aaron Hudson   |   6 comments

Your personal accountings of life tell a story and everyone’s numbers paint a different picture. This is an account of one 7-year-old boy in the battle against neuroblastoma cancer and what his numbers look like.


Interview with the Canadian Cancer Research Alliance (CCRA)

February 17th, 2014   |   Posted in Investment   |   By: Antonia Palmer   |   0 comments

Neuroblastoma Canada interviews two authors from the CCRA’s report on the current state of financial investment into pediatric cancer research in Canada.


Current and Future Strategies for Relapsed Neuroblastoma

July 19th, 2013   |   Posted in Relapse, Treatment   |   By: Antonia Palmer   |   1 comment

Navigating the options available for relapsed treatment is incredibly difficult and is done without a set of established and well-entrenched guidelines.


Back to Top